Siemens Healthineers is unveiling several updates to its imaging platforms at the RSNA annual meeting, with announcements on Sunday focusing on improved diagnostics in breast imaging and enhanced precision in interventional procedures through artificial intelligence.

The Erlangen, Germany-based company introduced new capabilities for its Mammomat B.brilliant system, including contrast-enhanced mammography (CEM) and biopsy enhancements. Central to the upgrade is a new image reconstruction method, ClearCEM, which is designed to improve lesion visibility, particularly in dense breast tissue.

ClearCEM delivers a more uniform image background and higher contrast differentiation, aiming to reduce the need for additional imaging or repeat biopsies. When a biopsy is required, the system now enables tomosynthesis-guided targeting with a contrast-enhanced localizer image, achieving a targeting accuracy of within ±1 mm. Siemens Healthineers says this continuity between diagnosis and biopsy within the same modality can help shorten time to diagnosis and increase system efficiency.
“The image quality with ClearCEM is exceptional, even in dense breast tissue,” said Dr. Dianne Georgian-Smith, a radiologist at Envision Healthcare, Nashville, Tennessee, who participated in clinical evaluations of the technique.

New AI to support interventional procedures
In parallel, Siemens Healthineers also debuted Optiq AI, an artificial intelligence-powered imaging chain now available on its latest interventional platforms, Artis genio, Artis icono.explore, and Artis icono.vision/Artis pheno.vision. The AI system is designed to improve low-dose image quality in real time by reducing system-generated noise before image formation. It supports multiple imaging modes, including fluoroscopy and digital subtraction angiography, across fields like interventional radiology and cardiology.

Optiq AI automatically adjusts parameters such as tube voltage and pulse width during procedures, responding dynamically to changes in angulation or collimation to maintain image quality while managing radiation dose.

“With Optiq AI, we are unlocking AI’s potential for a new generation of interventional systems,” said Carsten Bertram, head of advanced therapies at Siemens Healthineers. “Clinical staff and their patients benefit from accelerated workflows and better image quality.”

Both technologies reflect the company's broader focus on integrating AI and advanced imaging into routine clinical workflows to streamline care delivery and support earlier, more accurate diagnoses.

Artificial Intelligence Homepage